Diseases, Conditions, Syndromes

A COVID-19 vaccine breakthrough reported

The CUNY School of Medicine at The City College of New York and TechnoVax, Inc., a biotechnology developer of novel vaccines, announce a breakthrough in their collaborative effort to develop a vaccine for COVID-19. Scientists ...

Medical research

Lasting impact of COVID-19 infection on the immune system

A world leading research collaboration between SAHMRI, the University of Adelaide, Flinders University, the Women's and Children's Hospital and the Royal Adelaide Hospital has delivered crucial insight into the lasting immune ...

Diseases, Conditions, Syndromes

SARS-CoV-2 variants have developed resistance to human interferons

Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19. The study, published in Proceedings of the National ...

Alzheimer's disease & dementia

New drug may protect against memory loss in Alzheimer's disease

A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer's disease.

page 2 from 40